A Fine Line Between ‘Educating’ and ‘Scaring’ the Public: FTC Eyeing ‘Alarming’ Attorney Ads on Pharma

The FTC’s initiative—which comes in the wake of medical research and business groups’ expressions of concern—is aimed at curbing attorney ads that could cause people to become so concerned about the safety of their medications they simply stop taking them.

         
News
Author: News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *